Portfolio company
KinaSense
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops peptide-based biosensors and diagnostic methods to monitor kinase activity for cancer patients and clinical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kinomica Limited
This company develops a phosphoproteomic diagnostic platform to help clinicians and pharmaceutical firms select targeted cancer therapies for individual patients.
Kinnate Biopharma
The company develops small molecule kinase inhibitors for patients with difficult-to-treat cancers featuring specific genetic alterations.
SynsoryBio
SynsoryBio develops protein therapeutics designed to sense specific disease markers and activate only at targeted tissues to treat cancer and autoimmune disorders.
CanSense
This company develops blood-based diagnostic tests using laser spectroscopy and artificial intelligence for early-stage bowel cancer detection for healthcare providers and laboratories.
AminoSense
This company develops a biosensor platform for real-time amino acid measurement at home to help consumers optimize protein nutrition and metabolic health.
Biomesense
This company develops automated biosensors and analytics software for continuous gut microbiome tracking for clinical researchers, biotechnology firms and pharmaceutical organisations.
Sensys
This company develops non-invasive blood glucose monitors using infrared spectroscopy for patients managing diabetes.
Kascaid
This company develops interstitial fluid biosensors for real-time immune monitoring to support biopharma companies and researchers during clinical trials.
